HER2 Amplification Has no Prognostic Value in Sporadic and Hereditary Ovarian Tumours

Whereas HER2 amplification is a well-known phenomenon in breast tumours, its frequency and clinical importance in ovarian cancer have not been established. The aim of the study was to compare the frequency of HER2 amplification in hereditary (BRCA-positive) and sporadic (BRCA-negative) ovarian tumou...

Descripción completa

Detalles Bibliográficos
Autores principales: Brożek, Izabela, Kardaś, Iwona, Ochman, Karolina, Dębniak, Jarosław, Stukan, Maciej, Ratajska, Magdalena, Morzuch, Lucyna, Emerich, Janusz, Limon, Janusz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401919/
https://www.ncbi.nlm.nih.gov/pubmed/20223002
http://dx.doi.org/10.1186/1897-4287-4-1-39

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401919/
https://www.ncbi.nlm.nih.gov/pubmed/20223002
http://dx.doi.org/10.1186/1897-4287-4-1-39

Ejemplares similares